Significant Ownership of SUVRETTA CAPITAL MANAGEMENT, LLC

Signature - Title
/s/ Andrew Nathanson - Andrew Nathanson, General Counsel and Chief Compliance Officer
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by SUVRETTA CAPITAL MANAGEMENT, LLC.

Notify me when SUVRETTA CAPITAL MANAGEMENT, LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of SUVRETTA CAPITAL MANAGEMENT, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BNTC Benitec Biopharma Inc. Common Stock, par value $0.0001 44% $249,200,088 +$30,000,153 17,761,945 +14% SUVRETTA CAPITAL MANAGEMENT, LLC 07 Nov 2025
MOLN MOLECULAR PARTNERS AG Common Shares, CHF 0.10 nominal value per share 11% $16,710,743 4,284,806 SUVRETTA CAPITAL MANAGEMENT, LLC 15 Jun 2021
WHWK Aadi Bioscience, Inc. Common Stock, par value $0.0001 per share 10% $7,800,392 4,727,510 SUVRETTA CAPITAL MANAGEMENT, LLC 04 Mar 2025
DBVT DBV Technologies S.A. Ordinary shares, nominal value 0.10 euro per share 9.9% $107,294,426 15,176,015 SUVRETTA CAPITAL MANAGEMENT, LLC 07 Apr 2025
AVBP ArriVent BioPharma, Inc. Common Stock, $0.0001 Par Value per Share 9.9% $65,559,657 3,412,788 Suvretta Capital Management, LLC 30 Jun 2025
IMTX Immatics N.V. ordinary shares, nominal value (euro)0.01 per share 9.9% $63,519,081 +$15,286,128 12,030,129 +32% Suvretta Capital Management, LLC 30 Jun 2025
KURA Kura Oncology, Inc. Common Stock, par value $0.0001 per share 9.4% $45,139,170 +$14,105,982 7,561,000 +45% SUVRETTA CAPITAL MANAGEMENT, LLC 31 Mar 2025
FULC Fulcrum Therapeutics, Inc. Common Stock, par value $0.001 per share 9.4% $13,327,246 +$4,373,117 5,067,394 +49% SUVRETTA CAPITAL MANAGEMENT, LLC 31 Mar 2025
CMPX Compass Therapeutics, Inc. Common Stock, $0.0001 par value per share 8.2% $46,251,802 +$22,801,464 14,101,159 +97% Suvretta Capital Management, LLC 13 Aug 2025
STRO Sutro Biopharma, Inc. Common Stock, $0.001 par value 7.7% $5,579,959 6,488,324 Suvretta Capital Management, LLC 30 Jun 2025
AURA Aura Biosciences, Inc. Common Stock, par value $0.00001 per share 7.6% $30,561,538 +$10,688,964 4,701,775 +54% Suvretta Capital Management, LLC 30 Jun 2025
PVLA Palvella Therapeutics, Inc. Common stock, $0.001 par value per share 7.4% $51,556,256 +$6,766,571 822,400 +15% SUVRETTA CAPITAL MANAGEMENT, LLC 30 Sep 2025
ETNB 89bio, Inc. Common Stock, par value $0.001 per share 5.6% $121,716,000 -$93,071,712 8,280,000 -43% SUVRETTA CAPITAL MANAGEMENT, LLC 30 Sep 2025
GLUE Monte Rosa Therapeutics, Inc. Common stock, par value $0.0001 per share 5.5% $14,179,200 3,360,000 SUVRETTA CAPITAL MANAGEMENT, LLC 09 Apr 2025
MRNS Marinus Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 5.5% $1,662,437 +$504,541 3,022,612 +44% SUVRETTA CAPITAL MANAGEMENT, LLC 07 Feb 2025
ABEO Abeona Therapeutics Inc. Common Stock, $0.01 par value 5.2% $18,464,400 2,676,000 Suvretta Capital Management, LLC 30 Jun 2025
ERAS Erasca, Inc. Common Stock, $0.0001 par value per share 5.1% $22,913,166 +$3,455,460 14,502,004 +18% Suvretta Capital Management, LLC 30 Jun 2025
PEPG PepGen Inc. Common Stock, par value $0.0001 per share 0.9% $396,000 -$1,796,430 300,000 -82% SUVRETTA CAPITAL MANAGEMENT, LLC 30 Jun 2025

Schedules 13D/G Reported by SUVRETTA CAPITAL MANAGEMENT, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.